Related to this topic: Equipment | Books | Your Experience | Other resources | Glossaries
Print options: Printer friendly version of this leaflet (html)     Other options:  AddThis Social Bookmark Button (what's this?)

PatientPlus articles are written for doctors and so the language can be technical. However, some people find that they add depth to the articles found in the other sections of this website which are written for non-medical people.

Buerger's Disease

Synonyms: Thromboangiitis obliterans
This is a disease characterised by inflammation and thrombosis of the small and medium size arteries and veins of the hands and feet.

Epidemiology

The incidence is falling as the association with tobacco is recognised. In the USA it has fallen from around 100 per 100,000 people to less than 20 per 100,000. Women used to represent about 5% of cases but now they are about a third, reflecting smoking habits. It affects mostly men between the ages of 20 and 45. Recently it has been seen more in people over the age of 50.

There is considerable difference between races. It is more common in those of oriental race, including those from South-east Asia, India and the Middle East but it is less common in those of African origin. It is less common in people of northern European descent. Natives of India, Korea, and Japan, and especially Israeli Jews of Ashkenazi descent, have the highest incidence of the disease. Part of this difference in disease incidence may be due to variability in diagnostic criteria.1
Rarely it affects children with auto-immune phenomena and a strong level of inflammation.

The association of Buerger's Disease with tobacco use, particularly cigarette smoking, cannot be overemphasized.
Most patients with Buerger's disease are heavy smokers, but some cases occur in patients who smoke "moderately". It has been postulated that Buerger's Disease is an "autoimmune" reaction triggered by some constituent of tobacco.2

Presentation

Symptoms

The early symptoms of Buerger's Disease include claudication in the feet and/or hands, or pain in these areas at rest. The pain typically begins in the extremities but may radiate to more central parts of the body. Other signs and symptoms may include numbness and/or tingling in the limbs and Raynaud's phenomenon.

  • Pain or tenderness can be very intense and often at rest
  • Numbness and tingling in the limbs
  • Symptoms that may worsen with exposure to cold or emotional stress
  • Two or more limbs are affected
  • Pain may increase with activity such as walking and decrease with rest
  • Symptoms may worsen with exposure to cold or with emotional stress

Signs

  • Skin ulcerations and gangrene of the digits are common
  • Discoloration
  • Later symptoms include enlarged, red, tender cord-like veins
  • Pulses may be decreased or absent in the affected extremity
Differential Diagnosis

In the early stages other causes of Raynaud's phenomenon must be considered including SLE and scleroderma but the aggressive nature of Buerger's disease shows the true diagnosis as gangrene and ulceration set in. Exclude autoimmune diseases, hypercoagulable states and diabetes mellitus. A proximal source of embolism may be sought by echocardiography and arteriography.

Diagnostic Criteria

Diagnosis based on a system of scoring points has been suggested3 although some find this a little cumbersome and difficult.

Positive Points
Age of onset <30 +2, 30-40 +1
Foot intermittent claudication Present +2, from history +1
Upper extremity Symptomatic +2, asymptomatic +1
Migrating superficial vein thrombosis Present +2, by history only +1
Raynaud's phenomonon Present +2, by history only +1
Angiography or biopsy evidence Either +1, both +2
Negative Points
Age of onset 45-50 -1, >50 -2
Sex, smoking Female -1, non-smoker -2
Location Single limb -1, no lower limb involvement -2
Absent pulses Brachial -1, femoral -2
Arteriosclerosis, diabetes,
hypertension, hyperlipidaemia
Discovered after diagnosis. 1-5 years later -2,
5-10 years later -1

More recently, diagnostic criteria have been suggested from Japan.4 These are much simpler and easier to use.

  • Smoking history
  • Onset before the age of 50 years
  • Infrapopliteal arterial occlusions
  • Either upper limb involvement or phlebitis migrans
  • Absence of atherosclerotic risk factors other than smoking

Confident clinical diagnosis of Buerger's disease requires all 5 features. Strict clinical diagnostic criteria are essential for any study of a disease to ensure the homogeneity of the selected patient population for valid comparisons.

Investigations

There are no specific serological markers to diagnose Buerger's disease.

  • Recommended tests to rule out other causes of vasculitis include FBC, LFTs, creatinine, fasting glucose, ESR or PV, antinuclear antibody, rheumatoid factor, serologic markers for CREST syndrome and scleroderma, and screening for hypercoagulability.
  • Angiography - Certain angiographic features are typical of Buerger's disease. These include a "corkscrew" appearance of arteries that results from vascular damage, particularly the arteries in the region of the wrists and ankles. Angiograms may also show occlusions or stenoses in multiple areas of both the arms and legs. It is sometimes necessary to perform angiograms of other parts of the body regions, like a mesenteric angiogram to exclude other forms of vasculitis that involve vascular regions atypical for Buerger's.
  • A Doppler ultrasound may be helpful.
  • Skin biopsies of affected extremities are rarely performed because of fear that a biopsy site in an ischaemic area will not heal.
  • Echocardiography may be required to exclude a source of recurrent emboli
Management

Patients with Buerger's disease must stop smoking immediately and completely. This is the only treatment known to be effective.
Supportive measures include:

  • Gentle massage and warmth to increase circulation
  • Avoid conditions that reduce peripheral circulation, like cold temperatures
  • Avoid sitting or standing in one position for long periods
  • Do not walk barefoot to avoid injury
  • Avoid tight or restrictive clothing
  • Energetic treatment of any injuries (ulcers etc.)

The only way to prevent the progression of the disease is to abstain from all tobacco products. Avoid vasoconstricting drugs.

Drug Treatment

The drug iloprost, a prostacyclin analogue has been shown to be superior to low dose aspirin.5,6

Calcium channel blockers, steroids, anticoagulants and other antiplatelet drugs are ineffective.

If the disease is due to sensitivity to a component of tobacco other than nicotine then NRT may be used but prudence dictates that it should be continued for as short a time as possible.

Surgical

Sympathectomy may provide temporary relief but outcome is variable.7 Patients who continue to smoke are likely to require amputation of fingers and toes. Areas with gangrene must be removed surgically.

Complications

Ulcers, infection and gangrene must be treated energetically.

Prognosis

The disease is progressive in patients who do not stop smoking.

Historical Aspects

The first reported case was by von Winiwarter from Germany in1879 in an article entitled "A strange form of endarteritis and endophlebitis with gangrene of the feet." In 1908, Leo Buerger published a detailed description of the disease8 in which he referred to "presenile spontaneous gangrene." The paper discussed the pathological findings in 11 limbs amputated from Jewish patients in New York.

Leo Buerger was born in Vienna in 1879 but his parents emigrated to New York the following year. He studied at the College of Physicians and Surgeons, Columbia University, where he graduated in 1901. He studied at the Breslau Surgical Clinic in Germany for a time and then returned to private practice in New York where from 1905 he had an attachment to the Mount Sinai Hospital as professor of urological surgery.


Document References
  1. Olin JW; Thromboangiitis obliterans (Buerger's disease).;; N Engl J Med 2000 Sep 21;343(12):864-9.
  2. Papa M, Bass A, Adar R, et al; Autoimmune mechanisms in thromboangiitis obliterans (Buerger's disease): the role of tobacco antigen and the major histocompatibility complex.; Surgery. 1992 May;111(5):527-31. [abstract]
  3. Papa MZ, Rabi I, Adar R; A point scoring system for the clinical diagnosis of Buerger's disease.; Eur J Vasc Endovasc Surg. 1996 Apr;11(3):335-9. [abstract]
  4. Shionoya S; Diagnostic criteria of Buerger's disease.; Int J Cardiol. 1998 Oct 1;66 Suppl 1:S243-5; discussion S247. [abstract]
  5. Fiessinger JN, Schafer M; Trial of iloprost versus aspirin treatment for critical limb ischaemia of thromboangiitis obliterans. The TAO Study.; Lancet. 1990 Mar 10;335(8689):555-7. [abstract]
  6. No authors listed; Oral iloprost in the treatment of thromboangiitis obliterans (Buerger's disease): a double-blind, randomised, placebo-controlled trial. The European TAO Study Group.; Eur J Vasc Endovasc Surg. 1998 Apr;15(4):300-7. [abstract]
  7. Bozkurt AK, Besirli K, Koksal C, et al; Surgical treatment of Buerger's disease.; Vascular. 2004 May-Jun;12(3):192-7. [abstract]
  8. Buerger L. Thrombo-angiitis obliterans: a study of the vascular lesions leading to presenile spontaneous gangrene.; Am J Med Sci 1908; 136: 567-80.

Internet and Further Reading Acknowledgements EMIS is grateful to the Mentor authoring team for writing this article. The final copy has passed scrutiny by the independent Mentor GP reviewing team. ©EMIS 2007.
DocID: 1606
Document Version: 21
DocRef: bgp1219
Last Updated: 25 Sep 2006
Review Date: 24 Sep 2008
Patient UK Current Health News








Health Matters

Patient News



Disclaimer: Patient UK has no control of the content of the above links. Inclusion does not imply endorsement by Patient UK.

Advertise on this site



PS - Health and Poverty

Perhaps the biggest cause of ill health in the world is poverty. Help to Make Poverty History. For example, why not lend some of your money to disadvantaged communities to enable them to trade their way out of poverty through schemes such as Shared Interest.

See also MAKEPOVERTYHISTORY North East for details and links to campaigns against poverty.

^ Top of Page